Survodutide
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Red
Boehringer Ingelheim · Phase 3 · Completed · Enrollment 218
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Treatment arm | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo arm | Obesity or overweight | n/r | n/r | n/r | n/r |